Skip to main content

Fungal Disease

0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Kite Pharma
Kite PharmaCA - El Segundo
1 program
Patients received the Drug: liposomal amphotericin B（AmBisome） for treatmentN/A1 trial
Active Trials
NCT07357038Recruiting38Est. May 2027
Scynexis
ScynexisJERSEY CITY, NJ
1 program
IbrexafungerpPHASE_11 trial
Active Trials
NCT05668429Completed6Est. Jan 2023

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
2027
ScynexisIbrexafungerp
Kite PharmaPatients received the Drug: liposomal amphotericin B（AmBisome） for treatment

Clinical Trials (2)

Total enrollment: 44 patients across 2 trials

NCT05668429ScynexisIbrexafungerp

ADME Study of [14^C]-Ibrexafungerp in Healthy Male Subjects

Start: Dec 2022Est. completion: Jan 20236 patients
Phase 1Completed
NCT07357038Kite PharmaPatients received the Drug: liposomal amphotericin B（AmBisome） for treatment

A Real-world Prospective Observational Study on the Efficacy and Safety of L-AmB(Liposomal Amphotericin B) for br- IFD(Breakthrough Invasive Fungal Disease) in Children and Adolescent Patients With Hematological Malignancies Receiving Triazoles or Echinocandins Prophylaxis

Start: Sep 2025Est. completion: May 202738 patients
N/ARecruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 44 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.